Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kathleen M. Schmainda
Medical College of Wisconsin, Department: Radiation Diagnostic/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Imaging Biometrics, LLC
Salary not from the awardee Institution
Perfusion and diffusion MRI analysis methods, developed in the laboratory of Dr Schmainda, with funding from previous cycles of NIH (R01 CA082500), have been licensed by Imaging Biometrics and incorporated into MRI analysis software products. Current R01 (CA082500) research involves the development and testing of newer perfusion and diffusion MRI technology. This information would apply to both lines of disclosed SFI noted here.
MRI Contrast Agent Methods to Assess Tumor Angiogenesis
This RO1 competitive renewal proposes the development and validation of a combined perfusion and diffusion MRI (magnetic resonance imaging) approach to monitor the growth and treatment of brain tumors. Given that standard MRI methods to monitor treatment response have been found lacking this addresses an urgent clinical need. The perfusion technology is based on developments made over the past twelve years in the PI's laboratory and therefore may represent the most comprehensive and accurate solution to monitoring tumor vessel growth. This combined with recent advances in diffusion imaging, which provide complementary information about tumor cell invasion, has the potential to change the way by which brain tumor treatments are monitored and aid in the discovery of new treatments and combinations.
Filed on October 21, 2013.
Tell us what you know about Kathleen M. Schmainda's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Kathleen M. Schmainda filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Kathleen Schmainda | Medical College of Wisconsin | Conflict of Interest | Flying Brands, Ltd | $200,000 - $249,999 |
| Kathleen Schmainda | Medical College of Wisconsin | Conflict of Interest | Flying Brands, Ltd | $100,000 - $149,999 |
| Kathleen M. Schmainda | Medical College of Wisconsin | Conflict of Interest | Imaging Biometrics, LLC | $0 - $4,999 |
| Kathleen M. Schmainda | Medical College of Wisconsin | Conflict of Interest | Imaging Biometrics, LLC | $0 - $4,999 |
| Kathleen M. Schmainda | Medical College of Wisconsin | Conflict of Interest | Imaging Biometrics, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.